537 related articles for article (PubMed ID: 18574706)
1. In vitro activity of Penicillium chrysogenum antifungal protein (PAF) and its combination with fluconazole against different dermatophytes.
Galgóczy L; Papp T; Pócsi I; Hegedus N; Vágvölgyi C
Antonie Van Leeuwenhoek; 2008 Oct; 94(3):463-70. PubMed ID: 18574706
[TBL] [Abstract][Full Text] [Related]
2. Antifungal susceptibilities of dermatophytic agents isolated from clinical specimens.
Cetinkaya Z; Kiraz N; Karaca S; Kulac M; Ciftci IH; Aktepe OC; Altindis M; Kiyildi N; Piyade M
Eur J Dermatol; 2005; 15(4):258-61. PubMed ID: 16048753
[TBL] [Abstract][Full Text] [Related]
3. Antifungal activity of Ocimum gratissimum towards dermatophytes.
Silva MR; Oliveira JG; Fernandes OF; Passos XS; Costa CR; Souza LK; Lemos JA; Paula JR
Mycoses; 2005 May; 48(3):172-5. PubMed ID: 15842332
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the growth in vitro of Trichophyton mentagrophytes, Trichophyton erinacei and Microsporum persicolor by miconazole and chlorhexidine.
Perrins N; Howell SA; Moore M; Bond R
Vet Dermatol; 2005 Oct; 16(5):330-3. PubMed ID: 16238813
[TBL] [Abstract][Full Text] [Related]
5. Use of the sensititre colorimetric microdilution panel for antifungal susceptibility testing of dermatophytes.
Pujol I; Capilla J; Fernández-Torres B; Ortoneda M; Guarro J
J Clin Microbiol; 2002 Jul; 40(7):2618-21. PubMed ID: 12089289
[TBL] [Abstract][Full Text] [Related]
6. In vitro susceptibility of dermatomycoses agents to six antifungal drugs and evaluation by fractional inhibitory concentration index of combined effects of amorolfine and itraconazole in dermatophytes.
Tamura T; Asahara M; Yamamoto M; Yamaura M; Matsumura M; Goto K; Rezaei-Matehkolaei A; Mirhendi H; Makimura M; Makimura K
Microbiol Immunol; 2014 Jan; 58(1):1-8. PubMed ID: 24215461
[TBL] [Abstract][Full Text] [Related]
7. Susceptibility of clinically important dermatophytes against statins and different statin-antifungal combinations.
Nyilasi I; Kocsubé S; Krizsán K; Galgóczy L; Papp T; Pesti M; Nagy K; Vágvölgyi C
Med Mycol; 2014 Feb; 52(2):140-8. PubMed ID: 24004389
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of Citrus bergamia (bergamot) oil against clinical isolates of dermatophytes.
Sanguinetti M; Posteraro B; Romano L; Battaglia F; Lopizzo T; De Carolis E; Fadda G
J Antimicrob Chemother; 2007 Feb; 59(2):305-8. PubMed ID: 17118937
[TBL] [Abstract][Full Text] [Related]
9. In vitro activities of four antifungal drugs against Trichophyton rubrum isolates exhibiting resistance to fluconazole.
Santos DA; Hamdan JS
Mycoses; 2007 Jul; 50(4):286-9. PubMed ID: 17576321
[TBL] [Abstract][Full Text] [Related]
10. Ultrastructural changes on clinical isolates of Trichophyton rubrum, Trichophyton mentagrophytes, and Microsporum gypseum caused by Solanum chrysotrichum saponin SC-2.
López-Villegas EO; Herrera-Arellano A; de Los Angeles Martínez-Rivera M; Alvarez L; Cano-Nepauseno M; Marquina S; Rodríguez-Tovar AV; Tortoriello J
Planta Med; 2009 Nov; 75(14):1517-20. PubMed ID: 19551614
[TBL] [Abstract][Full Text] [Related]
11. In vitro evaluation of griseofulvin against clinical isolates of dermatophytes from Isfahan.
Chadeganipour M; Nilipour S; Havaei A
Mycoses; 2004 Dec; 47(11-12):503-7. PubMed ID: 15601457
[TBL] [Abstract][Full Text] [Related]
12. In vitro antifungal susceptibility patterns of dermatophyte strains causing tinea unguium.
Sarifakioglu E; Seçkin D; Demirbilek M; Can F
Clin Exp Dermatol; 2007 Nov; 32(6):675-9. PubMed ID: 17714532
[TBL] [Abstract][Full Text] [Related]
13. In vitro evaluation of antifungal susceptibility and keratinase, elastase, lipase and DNase activities of different dermatophyte species isolated from clinical specimens in Iran.
Sharifzadeh A; Shokri H; Khosravi AR
Mycoses; 2016 Nov; 59(11):710-719. PubMed ID: 27291045
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of Tachyplesin III alone and in combination with terbinafine against clinical isolates of dermatophytes.
Simonetti O; Ganzetti G; Arzeni D; Campanati A; Marconi B; Silvestri C; Cirioni O; Gabrielli E; Lenci I; Kamysz W; Kamysz E; Giacometti A; Scalise G; Barchiesi F; Offidani A
Peptides; 2009 Oct; 30(10):1794-7. PubMed ID: 19591887
[TBL] [Abstract][Full Text] [Related]
15. In vitro antifungal activity of extracts and neolignans from Piper regnellii against dermatophytes.
Koroishi AM; Foss SR; Cortez DA; Ueda-Nakamura T; Nakamura CV; Dias Filho BP
J Ethnopharmacol; 2008 May; 117(2):270-7. PubMed ID: 18394835
[TBL] [Abstract][Full Text] [Related]
16. In vitro pharmacodynamic characteristics of griseofulvin against dermatophyte isolates of Trichophyton tonsurans from tinea capitis patients.
Gupta AK; Williams JV; Zaman M; Singh J
Med Mycol; 2009 Dec; 47(8):796-801. PubMed ID: 19212895
[TBL] [Abstract][Full Text] [Related]
17. Sensitivity of different zygomycetes to the Penicillium chrysogenum antifungal protein (PAF).
Galgóczy L; Papp T; Leiter E; Marx F; Pócsi I; Vágvölgyi C
J Basic Microbiol; 2005; 45(2):136-41. PubMed ID: 15812858
[TBL] [Abstract][Full Text] [Related]
18. Antifungal potential of essential oil and various organic extracts of Nandina domestica Thunb. against skin infectious fungal pathogens.
Bajpai VK; Yoon JI; Kang SC
Appl Microbiol Biotechnol; 2009 Jul; 83(6):1127-33. PubMed ID: 19415265
[TBL] [Abstract][Full Text] [Related]
19. Antifungal activity of Eugenia umbelliflora against dermatophytes.
Machado KE; Cechinel Filho V; Cruz RC; Meyre-Silva C; Cruz AB
Nat Prod Commun; 2009 Sep; 4(9):1181-4. PubMed ID: 19831024
[TBL] [Abstract][Full Text] [Related]
20. Susceptibility of dermatophyte isolates obtained from a large worldwide terbinafine tinea capitis clinical trial.
Ghannoum MA; Wraith LA; Cai B; Nyirady J; Isham N
Br J Dermatol; 2008 Sep; 159(3):711-3. PubMed ID: 18510668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
